BioVie to host live investor webinar with CEO presentation and Q&A
PUBT · 17h ago
Share
Listen to the news
- BioVie will host a live investor webinar on June 2, 2026 at 4:15 p.m. ET.
- CEO Cuong Do is set to discuss bezisterim (NE3107) development progress in neuroinflammatory diseases.
- Presentation also expected to cover BIV201, its late-stage program for refractory ascites, followed by a live Q&A.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioVie Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605270800PRIMZONEFULLFEED9726882) on May 27, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending